Oncolys BioPharma Inc. (TYO:4588)
Japan flag Japan · Delayed Price · Currency is JPY
7,460.00
-160.00 (-2.10%)
Nov 18, 2026, 10:50 AM JST

Oncolys BioPharma Revenue

Oncolys BioPharma had revenue of 24.72M JPY in the quarter ending September 30, 2026, a decrease of -13.41%. This brings the company's total for the last twelve months to 28.55M, down -9.04% year-over-year. In the year 2024, Oncolys BioPharma had annual revenue of 31.38M, down -50.21%. That makes Oncolys BioPharma the 45,632nd largest company in the world by revenue and 3,872nd in Japan.

Revenue (ttm)
28.55M
Revenue Growth
-9.04%
P/S Ratio
7,887.49
Revenue / Employee
679.67K
Employees
45
Market Cap
220.43B

Revenue Chart

Revenue by Geography

  • Japan 35.00M 55.5%
  • United States of America 28.04M 44.5%
Fiscal year ended Dec 31, 2023 See the full Oncolys BioPharma breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202431.38M-31.65M-50.21%
Dec 31, 202363.04M-913.14M-93.54%
Dec 31, 2022976.18M333.69M51.94%
Dec 31, 2021642.49M328.32M104.50%
Dec 31, 2020314.18M-989.67M-75.90%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2011 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
GNI Group37.21B
Nxera Pharma35.51B
PeptiDream20.48B
3-D Matrix11.92B
RaQualia Pharma4.02B
Heartseed3.03B
Japan Tissue Engineering2.68B
Cuorips72.00M
Revenue Rankings